Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group.
Ester OrlandiPierluigi BonomoLetizia FerellaElisa D'AngeloMarta MaddaloDaniela AlterioGabriele InfanteAlmalina BacigalupoAngela ArgenoneNicola Alessandro IacovelliIsacco DesideriBruno MeduriLuca TriggianiStefania VolpeLiliana BelgioiaFrancesco DionisiDomenico Attilio RomanelloCarlo FallaiRosalba MiceliPublished in: Head & neck (2019)
Our data reinforce the survival benefit of Re-RT for selected patients with RSPHNC. MIRI RPA was not validated in our population.